Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZBH
āļāļ·āđāļāļāļĢāļīāļĐāļąāļZimmer Biomet Holdings Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 25, 2001
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ2001
āļāļĩāļāļĩāđāļMr. Ivan Tornos
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ17000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJul 25
āļāļĩāđāļāļĒāļđāđ345 E Main St
āđāļĄāļ·āļāļWARSAW
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ46580-2746
āđāļāļĢāļĻāļąāļāļāđ15742676131
āđāļ§āđāļāđāļāļāđhttps://www.zimmerbiomet.com/en
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZBH
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 25, 2001
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ2001
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
Ms. Betsy J. Bernard
Independent Director
Mr. Syed A. Jafry
Independent Director
Mr. Robert A. Hagemann
Independent Director
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
Ms. Betsy J. Bernard
Independent Director
VanEck Morningstar Wide Moat Value ETF
Langar Global HealthTech ETF
Leatherback Long/Short Alternative Yield ETF
VanEck Morningstar ESG Moat ETF
American Century Focused Large Cap Value ETF
VanEck Morningstar Wide Moat ETF
iShares U.S. Medical Devices ETF
Invesco Bloomberg Pricing Power ETF
SPDR S&P Health Care Equipment ETF
First Trust Indxx Medical Devices ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļāļŠāđāļ§āļ4.09%
Langar Global HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ2.94%
Leatherback Long/Short Alternative Yield ETF
āļŠāļąāļāļŠāđāļ§āļ2.82%
VanEck Morningstar ESG Moat ETF
āļŠāļąāļāļŠāđāļ§āļ2.41%
American Century Focused Large Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ2.31%
VanEck Morningstar Wide Moat ETF
āļŠāļąāļāļŠāđāļ§āļ2.22%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ2.05%
Invesco Bloomberg Pricing Power ETF
āļŠāļąāļāļŠāđāļ§āļ1.91%
SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.77%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.62%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
996.70M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ